These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6801811)

  • 21. Biochemical and in vivo properties of commercial virus-inactivated factor VIII concentrates.
    Berntorp E; Nilsson IM
    Eur J Haematol; 1988 Mar; 40(3):205-14. PubMed ID: 3128452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
    Tran TH; Duckert F
    Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of various factor VIII concentrates used in treatment of haemophilia A.
    Nilsson IM; Hedner U
    Br J Haematol; 1977 Dec; 37(4):543-57. PubMed ID: 304740
    [No Abstract]   [Full Text] [Related]  

  • 25. Carriers and noncarriers of haemophilia A: I. Multivariate analysis of pedigree data, screening blood coagulation tests and factor VIII variables.
    Wahlberg T; Blombäck M; Brodin U
    Thromb Res; 1982 Mar; 25(5):401-14. PubMed ID: 6803389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryoprecipitate and Factor VIII commercial concentrates: in vitro characteristics and in vivo compartmental analysis.
    Morfini M; Longo G; Matucci M; Vannini S; Messori A; Filimberti E; Duminuco M; Avanzi G; Rossi-Ferrini P
    Ric Clin Lab; 1984; 14(4):681-91. PubMed ID: 6441235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional and immunological assays of FVIII in 133 haemophiliacs--characterization of a subgroup of patients with mild haemophilia A and discrepancy in 1- and 2-stage assays.
    Parquet-Gernez A; Mazurier C; Goudemand M
    Thromb Haemost; 1988 Apr; 59(2):202-6. PubMed ID: 3133808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carrier detection in haemophilia a by immunological measurement of factor VIII related antigen (VIIIRAg) and factor VIII clotting antigen (VIIICAg).
    Peake IR; Newcombe RG; Davies BL; Furlong RA; Ludlam CA; Bloom AL
    Br J Haematol; 1981 Aug; 48(4):651-60. PubMed ID: 6791679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of anamnestic response after transfusion of washed red blood cells in haemophilia A patients with antibody to factor VIII.
    Laurian Y; Girma JP; Allain JP; Verroust F; Larrieu MJ
    Scand J Haematol; 1982 Mar; 28(3):233-7. PubMed ID: 6806896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determination of factor VIII antigen (VIIIR-Ag) by erythrocyte agglutination].
    Coelho E
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(6):273-6. PubMed ID: 3138751
    [No Abstract]   [Full Text] [Related]  

  • 31. Experience in the laboratory detection of the carrier state of classic hemophilia.
    Hohn DE; Fisher LM
    Am J Med Technol; 1979 Apr; 45(4):294-6. PubMed ID: 433979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of a competitive enzyme immunoassay for factor VIII-related antigen].
    Riemer J; Kopperschläger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(1):72-83. PubMed ID: 6202602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An immunoradiometric assay for procoagulant factor VIII antigen: results in haemophilia, von Willebrand's disease and fetal plasma and serum.
    Peake IR; Bloom AL; Giddings JC; Ludlam CA
    Br J Haematol; 1979 Jun; 42(2):269-81. PubMed ID: 313808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor VIII concentrates contain factor VIII procoagulant antigen bound to phospholipid.
    Kemball-Cook G; Barrowcliffe TW
    Br J Haematol; 1986 Jul; 63(3):425-34. PubMed ID: 3089269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of high molecular weight factor VIII on the measurement of low molecular weight factor VIII procoagulant in different assay systems.
    Muntean W; Hathaway WE; Montgomery RR
    Br J Haematol; 1982 Aug; 51(4):649-58. PubMed ID: 6809034
    [No Abstract]   [Full Text] [Related]  

  • 36. Kinetic analysis of bovine factor VIII in the hemophilic dog.
    Gentry PA; Kirby EP; Gentry RD
    Thromb Haemost; 1981 Aug; 46(2):485-8. PubMed ID: 6795739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
    Ballard JO; Sanders JC; Eyster ME
    Thromb Haemost; 1981 Feb; 45(1):68-72. PubMed ID: 6166064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Determination of factor VIII-coagulation antigen in factor VIII concentrates using an inhibitor test].
    Im T; Hintz G
    Arzneimittelforschung; 1986; 36(1):124-6. PubMed ID: 3082340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of carrier detection in haemophilia A by linear discriminant function.
    Shen MC
    Br J Haematol; 1982 Oct; 52(2):283-93. PubMed ID: 6812614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unsuitability of laser nephelometer in the evaluation of factor VIII antigen.
    Ruzza G; Viero M; Lazzaro AR; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):269-75. PubMed ID: 2475407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.